MDVerse
About:
MDVerse develops regenerative medicine for drug development, manufacturing, and clinical trials.
Website: https://mdverse.io
Top Investors: PGV
Description:
MDVerse develops regenerative medicine for drug development, manufacturing, and clinical trials. The company uses disruptive technologies to help pharmaceutical companies, academic institutions, and clinical sites develop and deliver personalized, precision therapies more quickly and efficiently.
Total Funding Amount:
$750000
Headquarters Location:
Fremont, California, United States
Founded Date:
2022-01-01
Founders:
Dawn Daniel, Subra Ramesh
Number of Employees:
1-10
Last Funding Date:
2023-01-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai